The results of the multifactorial LR analysis indicate that C-reactive protein (CRP), fibrinogen, von Willebrand factor (vWF), factor VIII (FVIII), and treatment regimen immunomodulator in the patient’s treatment regimen are independent factors influencing the risk of VTE in patients with MM. The gene discussed is CRP; the disease is Miyoshi myopathy.